BiotechTube
Home/Acepodia/Michael Kurman, M.D.
MK

Michael Kurman, M.D.

Head of Clinical Development

Acepodia

Therapeutic Areas

OncologyAutoimmune Diseases

Acepodia Pipeline

DrugIndicationPhase
ACE1831Non-Hodgkin's LymphomaPhase I
ACE2016EGFR-expressing Solid TumorsPhase I
AD2C ProgramHepatocellular Carcinoma (targeting GPC3)Preclinical

Leadership Team at Acepodia

SH
Sonny Hsiao, Ph.D.
Chairman and CEO
PY
Patrick Y. Yang, Ph.D.
Co-Founder
JW
Jennifer Wang, Ph.D.
Chief Technology Officer
CB
Carolyn Bertozzi, Ph.D.
Board of Directors, Chief Scientific Advisor
View full Acepodia profile